Inventia Healthcare Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Inventia Healthcare

DeciZen not available for IPO

10 Year X-Ray of Inventia Healthcare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18TTM
ROCE % 7.7%3.8%-3.9%1.5%6.1%2.8%3.8%10.5%12.5%13.3%-
Value Creation
Index
-0.5-0.7-1.3-0.9-0.6-0.8-0.7-0.3-0.1-0.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 117114135143170172196228265307307
Sales YoY Gr.--2.9%18.8%6%19%0.7%14.2%16.6%16%16%-
Adj EPS 2.93.6-1.10.36.115.5914.215.515
YoY Gr.-23.9%-129.8%NA1989.7%-83.3%439.6%65%57.7%9.5%-
BVPS (₹) 100.4123.4122.3122.7126.6127.4138148.3157.2167.4169.4
Adj Net
Profit
2.83.8-1.10.36.31.15.79.414.816.216
Cash Flow from Ops. 4.34.914.1814.314.66.67.231.10.3-
Debt/CF from Ops. 12.14.31.831.72.47.48.91.8337.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 11.3%12.5%16.2%16%
Adj EPS 20.4%20.7%41.8%9.5%
BVPS5.8%5.7%6.6%6.5%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18TTM
Return on
Equity %
4.43.4-0.90.24.90.84.16.39.39.68.9
Op. Profit
Mgn %
8.610.82.37.811.78.69.21114.514.7NAN
Net Profit
Mgn %
2.43.3-0.80.23.70.62.94.15.65.35.1
Debt to
Equity
0.50.20.20.20.20.30.30.40.30.6-
Working Cap
Days
1111491491151081111121351521850
Cash Conv.
Cycle
2255-440-569-88730436161610

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - Inventia Healthcare Ltd.

Standalone Consolidated
TTM EPS (₹) 15 -
TTM Sales (₹ Cr.) 307 -
BVPS (₹.) 169.4 -
Reserves (₹ Cr.) 167 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 10.4
Face Value (₹) 10
Industry PE 37.5

Quarterly Results

 Mar'24 YoY Gr. Rt. %Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %
Sales (₹ Cr.) 0 N/A0 N/A0 N/A0 N/A
Adj EPS (₹) 0 N/A0 N/A0 N/A0 N/A
Op. Profit Mgn % N/A N/AN/A N/AN/A N/AN/A N/A
Net Profit Mgn % N/A N/AN/A N/AN/A N/AN/A N/A

Management X-Ray of Inventia Healthcare:

Shareholding Pattern

JavaScript chart by amCharts 3.21.5
JavaScript chart by amCharts 3.21.5Promoters:76.4%Institutions:0%Non-Institutions:23.6%

Promoter's Holding & Share Pledging

JavaScript chart by amCharts 3.21.5Mar180%20%40%60%80%
Pledged *0.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Inventia Healthcare

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Inventia Healthcare

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Alembic Pharma 802.8 -10.6 (-1.3%) Small Cap 6,229 30.8 9.6 26.4 3.2
Laurus Labs 521.1 -15.4 (-2.9%) Small Cap 5,041 3.7 3.1 144.5 6.9
Piramal Pharma 208.6 -9.5 (-4.3%) Small Cap 4,390 5.2 8.4 42.1 4.1
Ajanta Pharma 2,607.3 -63.1 (-2.4%) Small Cap 4,209 71.9 19 37.2 8.5
Gland Pharma 1,524.3 3.9 (0.3%) Small Cap 4,167 68.1 24.8 22.3 2.7
Natco Pharma 797.8 4.8 (0.6%) Small Cap 3,999 104.1 34.5 7.6 2
Granules India 509 -18.4 (-3.5%) Small Cap 3,755 13.3 11.7 39.7 3.9
Emcure Pharma 996.8 5.2 (0.5%) Small Cap 3,498 8.5 4.4 116.8 6.5
JB Chem & Pharma 1,605.5 -25 (-1.5%) Small Cap 3,299 40.4 16.1 40.4 7.7
Sanofi India 5,076.8 -91.3 (-1.8%) Small Cap 2,851 184.4 20.8 28 15.5
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Sales117.03113.68135.05143.18170.31171.52195.83228.38264.85307.14
Operating Expenses 108.45101.81131.92132.06150.95156.76177.98203.37229.37263.45
Manufacturing Costs13.4415.7300012.1626.3230.6138.2542.97
Material Costs61.9457.901.47-1.01-4.6987.0592.76108.75117.14126.79
Employee Cost 16.8415.6600034.0137.0541.1243.7353.83
Other Costs 16.2312.52130.45133.07155.6323.5521.8522.8930.2439.86
Operating Profit 8.5711.873.1411.1219.3714.7617.8525.0135.4843.69
Operating Profit Margin (%) 7.3%10.4%2.3%7.8%11.4%8.6%9.1%11.0%13.4%14.2%
Other Income 3.662.3600.680.020.501.546.643.051.58
Interest 4.171.8301.881.852.892.285.193.237.11
Depreciation 6.648.509.069.5010.0510.779.851011.1612.03
Exceptional Items 3.8500000-2.78000
Profit Before Tax 5.293.91-5.930.427.481.604.4816.4524.1426.12
Tax 0.800.38-4.800.081.500.560.083.109.9610.42
Profit After Tax 4.483.53-1.130.345.981.044.4113.3514.1815.71
PAT Margin (%) 3.8%3.1%-0.8%0.2%3.5%0.6%2.2%5.8%5.4%5.1%
Adjusted EPS (₹)4.73.4-1.10.35.71.04.212.813.615.1
Dividend Payout Ratio (%)24%33%0%0%26%19%4%15%28%30%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18

Equity and Liabilities

Shareholders Fund 96.42128.58127.45127.79131.93132.75143.78154.52163.76174.36
Share Capital 7.227.837.837.837.837.837.837.837.837.83
Reserves 89.20120.74119.61119.95124.10124.91135.94146.69155.93166.52
Minority Interest0000000000
Debt52.4321.2417.1120.6919.8125.6436.6552.9044.4988.60
Long Term Debt52.4321.245.1110.0910.1018.0924.3922.3919.8046.89
Short Term Debt001210.619.727.5512.2630.5224.6941.71
Trade Payables7.5211.7718.0816.6921.4523.2723.8333.4440.1165.73
Others Liabilities 7.3128.6511.216.6912.9312.4114.5417.9425.1843.98
Total Liabilities 163.69190.23173.85171.86186.13194.07218.79258.80273.54372.66

Fixed Assets

Gross Block127.84142.86146.68156.13160.50172.01163.13180.87189.44145.54
Accumulated Depreciation11.6820.1228.1137.5047.3958.0569.2577.0687.9411.88
Net Fixed Assets116.16122.74118.57118.62113.11113.9693.88103.81101.50133.66
CWIP 5.971.746.778.7216.2924.9333.8833.4642.4250.21
Investments 00000013.7113.5600
Inventories9.0116.7715.3016.0420.7520.4335.3444.4949.2153.51
Trade Receivables13.8318.6516.7319.5920.3123.1025.1443.5347.1983.73
Cash Equivalents 8.881.172.580.470.100.983.664.051.942.39
Others Assets9.8329.1613.898.4215.5610.6713.1915.9031.2849.16
Total Assets 163.69190.23173.85171.86186.13194.07218.79258.80273.54372.66

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Cash Flow From Operating Activity 4.334.9114.077.9714.3214.626.617.1631.140.31
PBT 5.293.91-5.930.427.481.604.4816.4524.1426.12
Adjustment 7.299.8311.1411.0712.7714.8114.8711.1516.1617.57
Changes in Working Capital -6.28-9.188.97-3.04-5.68-0.94-10.34-17.53-3.21-37.85
Tax Paid -1.960.36-0.11000-2.39-2.91-5.95-5.53
Cash Flow From Investing Activity -29.32-11.14-13.67-6.90-13.99-19.06-16.79-10.64-18.19-40.41
Capex -25.17-16.36-14.17-7.35-13.77-19.10-14.79-12.47-7.79-50.28
Net Investments 0.390.400000-2.031.76-10.038.90
Others -4.544.820.500.45-0.220.050.030.07-0.370.97
Cash Flow From Financing Activity 32.77-1.441.55-4.22-1.135.1810.835.87-14.9639.10
Net Proceeds from Shares 603000000000
Net Proceeds from Borrowing 0-28.7739.9900-4.948.98-5.01-1.7232.63
Interest Paid -3.93-1.40-1.61-2.74-1.97-3.16-2.38-5.39-3.34-4.71
Dividend Paid 0-1.08-1.1700-1.57-0.20-1.96-3.92-4.70
Others -23.30-0.18-35.65-1.480.8414.854.4218.22-5.9915.88
Net Cash Flow 7.78-7.661.96-3.15-0.800.740.652.39-2.01-1
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Ratios
ROE (%)6.933.14-0.880.274.60.793.198.958.919.29
ROCE (%)7.673.84-3.921.516.062.773.7510.5112.4913.32
Asset Turnover Ratio0.870.680.740.830.950.961.011.011.040.96
PAT to CFO Conversion(x)0.971.39N/A23.442.3914.061.50.542.20.02
Working Capital Days
Receivable Days38504846434442526077
Inventory Days25394340394149616261
Payable Days68613,711-6,283-1,486949396115152

Inventia Healthcare Ltd Stock News

No data found.

Inventia Healthcare Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Inventia Healthcare on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Inventia Healthcare stood at ₹0.00.
The latest P/E ratio of Inventia Healthcare as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Inventia Healthcare as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Inventia Healthcare is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Inventia Healthcare is ₹307.1 ( Cr.) .

About Inventia Healthcare Ltd

No data to display
You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Loading...
Hold on